Using echocardiography in newborn screening for congenital heart disease may reduce missed diagnoses  

作　　者：Yun-Xiang Qiu Wei Jiang Jia-Yu Zhang Die Li Kai Yu Cang-Cang Fu Xiao-Min Tang Wei-Ze Xu 

机构地区：[1]Heart Center,Children’s Hospital,Zhejiang University School of Medicine,National Clinical Research Center for Child Health,No.3333 Binsheng Road,Binjiang District,Hangzhou,310000,China

出　　处：《World Journal of Pediatrics》2022年第9期629-631,共3页世界儿科杂志（英文版）

基　　金：supported in part by the Zhejiang Province Key Research and Development Project(2020C03120 and 2022C03087).

摘　　要：Congenital heart disease(CHD)is the most common type of birth defect in China.According to a national study,the overall prevalences of CHD and critical CHD were 8.98 per 1000 live births and 1.46 per 1000 live births,respectively,in China[1].CHD,particularly critical CHD,not only seri-ously affects the quality of life of patients and their family,but creates huge economic and mental burdens on the fam-ily and on society as a whole[2].Early diagnosis of CHD is imperative for early intervention and treatment.For early diagnosis of CHD,CHD screening in all newborns was first initiated in Shanghai,China on June 1,2016[3].Since July 30,2018,the China National Health Commission initiated newborn screening program for CHD;"double index meth-ods"(cardiac auscultation plus pulse oximetry)were used to screen CHD for newborns 6 hours and 72 hours after birth.

关 键 词：diagnosis CONGENITAL initiated 

分 类 号：R541[医药卫生—心血管疾病]